The risk of deep venous thrombosis with oral contraceptives containing drospirenone

BMJ

Volumn 342, Issue 7804, 2011, Pages

  Dunn, Nick ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; ALDOSTERONE ANTAGONIST; ANDROSTANE DERIVATIVE;

CLINICAL PRACTICE; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; GENERAL PRACTICE; HUMAN; LUNG EMBOLISM; ORAL CONTRACEPTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; UNITED KINGDOM; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; FEMALE; NOTE;

ALDOSTERONE ANTAGONISTS; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; FEMALE; HUMANS; VENOUS THROMBOEMBOLISM;

EID: 79955537875     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2519     Document Type: Editorial

References (8)

1. Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ 2011;342:d2139
2. Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data. BMJ 2011;342:d2151.
3. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ 2009;339:b2890.
4. Van Hylckama V, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA study. BMJ 2009;339:b2921.
5. Dinger, JC, Heinemann LAJ, Kuhle-Habich D. The safety of drospirenone containing oral contraceptive: final results from the European active surveillance study on all contraceptives based on 142 475 women years of observation. Contraception 2007;75:344-54. (Pubitemid 46551071)
6. Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives. Obstet Gynecol 2007;110:587-93. (Pubitemid 47359582)
7. Van Vliet HAAM, Winkel TA, Noort I, Rosing J, Rosendaal FR. Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate. J Thromb Haemost 2004;2:2060-2. (Pubitemid 40192767)
8. Arowogulu AO, Gallo MF, Lopez LM, Grimes DA, Garner SE. Combined oral contraceptive pills for the treatment of acne. Cochrane Database Syst Rev 2009;3:CD004425.